Cancer and depression: Theory and treatment

Psychiatric Annals

Volumn 27, Issue 5, 1997, Pages 360-364

  McDaniel, J Stephen ^a,b   Musselman, Dominique L ^a   Nemeroff, Charles B ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0031475731     PISSN: 00485713     EISSN: None     Source Type: Journal    
DOI: 10.3928/0048-5713-19970501-12     Document Type: Article

References (58)

1. Katon W, Sullivan MD. Depression and chronic medical illness. J Clin Psychiatry. 1990; 51(suppl 6):3-11.
2. Abram HS, Moore GL, Westervelt FB. Suicidal behavior in chronic dialysis patients. Am J Psychiatry. 1971; 127:1199-1204.
3. Hawton K. The long-term outcome of psychiatric morbidity detected in general medical patients. J Psychosom Res. 1981; 25:237-243.
4. Rodin GM, Chmara J, Ennis J. Stopping life-sustaining medical treatment: psychiatric considerations in the termination of renal dialysis. Can J Psychiatry. 1981; 26:540-544.
5. Murphy E, Smith R, Slatter J. Increased mortality rates in late-life depression. Br J Psychiatry. 1988; 152:347-353.
6. Koenig HG, Shelp F, Goli V, Cohen HJ, Blazer DG. Survival and healthcare utilization in elderly medical inpatients with major depression. J Am Geriatr Soc. 1989; 37:599-606.
7. Stoudemire A, Thompson TL. Medication noncompliance: systematic approaches to evaluation and intervention. Gen Hosp Psychiatry. 1983; 5:233-239.
8. Koenig HG, Cohen HJ, Blazer DG, Meador KG, Westlund R. A brief depression scale for use in the medically ill. Int J Psychiatry Med. 1992; 22:183-195.
9. Cavanaugh SA. The prevalence of emotional and cognitive dysfunction in a general medical population: using the MMSE, GHQ, and BDI. Gen Hosp Psychiatry. 1983; 5:15-24.
10. Berkman LF, Berkman CS, Kasl S, et al. Depressive symptoms in relation to physical health and functioning in the elderly. Am J Epidemiol. 1986; 124:372-388.
11. Cassileth BR, Lusk EJ, Strouse TB, et al. Psychological status in chronic illness: a comparative analysis of six diagnostic groups. N Engl J Med. 1984; 311:506-511.
12. Noyes R, Kathol RG. Depression and cancer. Psychiatr Dev. 1986; 2:77-100.
13. McDaniel JS, Nemeroff CB. Depression in the cancer patient: diagnostic, biological and treatment aspects. In: Chapman CR, Foley KM, eds. Current and Emerging Issues in Cancer Pain. New York, NY: Raven Press; 1993:1-19.
14. DeFlorio ML, Massie MJ. A review of cancer in depression: gender differences. Depression. 1995; 3:66-80.
15. McDaniel JS, Musselman DL, Porter MR, Reed DA, Nemeroff CB. Depression in patients with cancer: diagnosis, biology, and treatment. Arch Gen Psychiatry. 1995; 52:89-99.
16. Rouchell AM, Pounds R, Tierny JG. Depression. In: Rundell JR, Wise MG, eds. Textbook of Consultation-Liaison Psychiatry. Washington, DC: American Psychiatric Press, Inc; 1996:310-336.
17. Costa E, Mogos I, Toma T. Efficacy and safety of mianserin in the treatment of depression in women with cancer. Acta Psychiatr Scand. 1985; 72:85-92.
18. Evans DL, McCartney CF, Haggerty JJ. Treatment of depression in cancer patients is associated with better life adaptation: a pilot study. Psychosom Med. 1988; 50:72-76.
19. Spiegel D, Bloom JR, Kraemer HC, Gottheil E. Effect of psychosocial treatment on survival of patients with metastatic breast cancer. Lancet. 1989; 2:888-891.
20. Richardson J, Sheldon D, Krailo M, Levine A. The effect of compliance with treatment on survival among patients with hematologic malignancies. J Clin Oncol. 1990; 8:356-364.
21. Fawzy FI, Fawzy NW, Hyun CS, et al. Malignant melanoma: effects of an early structured psychiatric intervention, coping, and affective state on recurrence and survival six years later. Arch Gen Psychiatry. 1993; 50:681-689.
22. Diagnostic and Statistical Manual. 4th ed. Washington, DC: American Psychiatric Press Inc; 1994.
23. Kathol RG, Mutgi A, Williams J, Clamon G, Noyes R. Diagnosis of major depression in cancer patients according to four sets of criteria. Am J Psychiatry. 1990; 147:1021-1024.
24. Kathol RG, Noyes R, Williams J, Mutgi A, Carroll B, Perry P. Diagnosing depression in patients with medical illness. Psychosomatics. 1990; 31:434-440.
25. Cavanaugh SA. Depression in the medically ill: critical issues in diagnostic assessment. Psychosomatics. 1995; 36:48-59.
26. Bukberg J, Penman D, Holland JC. Depression in hospitalized cancer patients. Psychiatric Medicine. 1984; 46:199-212.
27. Cohen-Cole SA, Brown FW, McDaniel JS. Diagnostic assessment of depression in the medically ill. In: Stoudemire A, Fogel B, eds. Psychiatric Care of the Medical Patient. New York, NY: Oxford University Press; 1993:53-70.
28. Mermelstein HT, Lesko L. Depression in patients with cancer. Psycho-oncology. 1992; 1:199-215.
29. Quitkin FM, Stewart JW, Morison AW. Antidepressants for mild depressives. Presented at the 143rd Annual Meeting of the American Psychiatric Association; New York, NY; May 23, 1990.
30. Weissman A, Worden J. The existential plight in cancer: significance of the first 100 days. Psychiatric Medicine. 1976; 7:1-15.
31. Plumb M, Holland J. Comparative studies of psychological function in patients with advanced cancer, II: interviewer-rated current and past psychological symptoms. Psychosom Med. 1981; 43:243-254.
32. Massie MJ, Holland JC. The cancer patient with pain. Med Clin North Am. 1987; 71:243-258.
33. Holland JC, Korzun AH, Tross S, et al. Comparative psychological disturbance in patients with pancreatic and gastric cancer. Am J Psychiatry. 1986; 143:982-986.
34. Breitbart W. Identifying patients at risk for, and treatment of major psychiatric complications of cancer. Support Care Cancer. 1995; 3:45-60.
35. Breitbart W. Suicide risk and pain in cancer and AIDS patients. In Chapman CR, Foley KM, eds. Current and Emerging Issues in Cancer Pain. New York, NY: Raven Press; 1993:1-19.
36. Bolund C. Suicide and cancer, II: medical and care factors in suicide by cancer patients in Sweden, 1973-1976. Journal of Psychosocial Oncology. 1985; 3:17-30.
37. Lesko L, Massie M, Holland J. Oncology. In: Stoudemire A, Fogel B, eds. Psychiatric Care of the Medical Patient. New York, NY: Oxford University Press; 1993:565-590.
38. Robeiro SCM, Tandon R, Grunhaus L, Greden JF. The DST as a predictor of outcome in depression: a metaanalysis. Am J Psychiatry. 1993; 150:1618-1629.
39. Musselman DL, McDaniel JS, Porter MR, Nemeroff CB. Mechanisms by which psychological and social factors may alter cancer risk: psychoneuroendocrinology. In: Holland J, ed. Textbook of Psycho-oncology. 2nd ed. New York, NY: Oxford University Press. In press.
40. Schuckit MA. Trait (and state) markers of a predisposition to psychopathology. In: Michels R, Cavenar JO, Cooper AM, et al, eds. Psychiatry. Philadelphia, Pa: JB Lippincott Co; 1988; 53:1-19.
41. Evans DL, McCartney CF, Nemeroff CB, et al. Depression in women treated for gynecological cancer: clinical and neuroendocrine assessment. Am J Psychiatry. 1986; 143:447-452.
42. McDaniel JS, Nemeroff CB. Psychological distress and depression. In: Abeloff M, Armitage J, Lichter A, Neiderhuber J, eds. Clinical Oncology. New York, NY: Churchill Livingstone, Inc; 1995:373-391.
43. Purhoit DR, Navlakha PL, Mode RS, Eshpumiyani R. The role of antidepressants in hospitalized cancer patients. J Assoc Physicians India. 1978; 26:245-248.
44. Massie MJ, Lesko LM. Psychopharmacological management. In: Holland JC, Rowland JH, eds. Handbook of Psychooncology. New York NY: Oxford University Press; 1989:470-491.
45. Porter MR, Musselman DL, McDaniel JS, Nemeroff CB. From sadness to major depression: assessment and management in patients with cancer. In: Bruera E, Portenoy R, eds. Supportive Care Medicine. In press.
46. Fawzy FI, Greenberg DB. Oncology. In: Rundell JR, Wise MG, eds. Textbook of Consultation-Liaison Psychiatry. Washington, DC: American Psychiatric Press, Inc; 1996:672-295.
47. Woods S, Tesar G, Murray G, Cassem N. Psychostimulant treatment of depressive disorders secondary to medical illness. J Clin Psychiatry. 1986; 47:12-15.
48. Bruera E, MacDonald N, Chadwisk S, Brennis C. Double-blind crossover study of methylphenidate with narcotics for the treatment of cancer pain. Proceedings of the American Society of Clinical Oncology. 1986; 989:253. Abstract.
49. Beale MD, Kellner CH. Electroconvulsive therapy: an overview. In: Rundell JR, Wise MG, eds. Textbook of Consultation-Liaison Psychiatry. Washington, DC: American Psychiatric Press, Inc; 1996:1038-1051.
50. Fawzy FI, Fawzy NW, Arndt LA, Pasnau RO. Critical review of psychosocial interventions in cancer care. Arch Gen Psychiatry. 1995; 52:100-113.
51. Levenson JL, Bemis C. Cancer onset and progression. In: Stoudemire A, ed. Washington, DC: American Psychiatric Press, Inc; 1995:81-98.
52. Fawzy FI, Kemeny ME, Fawzy NW, et al. A structured psychiatric intervention for cancer patients, II: changes over time in immunological measures. Arch Gen Psychiatry. 1990; 47:729-735.
53. Gruber BL, Hersh SP, Hall NRS, et al. Immunological responses to breast cancer patients to behavioral interventions. Biofeedback Self Regul. 1993; 18:1-22.
54. Bovbjerg DH. Psychoneuroimmunology: implications for oncology. Cancer. 1991; 67(suppl):828-832.
55. Levy SM, Herberman RB, Lippman M, d'Angelo T. Correlation of stress factors with sustained depression of natural killer cell activity and predicted prognosis in patients with breast cancer. J Clin Oncol. 1987; 5:348-353.
56. Levy SM, Herberman RB, Whitside T, Sanzo K, Lee J, Kirkwood J. Perceived social support and tumor estrogen/progesterone receptor status as predictors of natural killer cell activity in breast cancer patients. Psychosom Med. 1990; 42:73-85.
57. Sapolosky RM, Donnelly TM. Vulnerability to stress-induced tumor growth increases with age: role of glucocorticoids. Endocrinology: 1985; 117:662-666.
58. Schedlowski M, Jung C, Schimanski G, Tewes U, Schmoll HJ. Effects of behavioral intervention on plasma cortisol and lymphocytes in breast cancer patients: an exploratory study. Psycho-oncology. 1994; 3:181-187.